Paraparesis, Tropical Spastic - 19 Studies Found
Completed |
: Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial : HTLV-I-associated Myelopathy : 2006-01-04 : Drug: Zidovudine/lamivudine |
Completed |
: Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) : HTLV-I-Associated Myelopathy : 2011-04-25 : Drug: Tamibarotene Oral administration of tamibarotene 2 mg daily over a period of 12 weeks, then 4mg da |
Completed |
: MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis : Tropical Spastic Paraparesis : 2002-05-01 |
Completed |
: Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) : HTLV I Associated Myelopathy : 2008-10-15 : Drug: ciclosporin Ciclosporin 2.5 - 5mg/kg/day in two equally divided doses. dose adjusted according to |
Not yet recruiting |
: Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection :
: 2015-11-16 : Drug: "Raltegravir" and "Zidovudine" Through measure of pro-viral load and clinical |
Completed |
: Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM) :
|
Terminated |
: The HAM Infliximab Study : HTLV-I-associated Myelopathy : 2009-01-14 : Drug: Infliximab Infliximab 3mg/kg infused intravenously at weeks 0, 2 and 8 and then every 8 weeks unti |
Terminated |
: Safety and Efficiency Study of Valproic Acid In HAM/TSP : HTLV-I-Associated Myelopathy : 2007-08-20 : Drug: Valproic Acid Valproic acid by oral route (20mg/Kg/day) during one year. |
Completed |
: A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis : HTLV-I : 2006-06-19 |
Recruiting |
: Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis : HTLV-1 : 2006-07-12 : Drug: Hu MiK-Beta-1 |